Cargando…

IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand

IL-35 is known as a regulatory cytokine produced by regulatory T cells. It has also been reported that IL-35 suppresses the proliferation of Th17 cells, which is involved in the pathogenesis of many autoimmune diseases. However, in rheumatoid arthritis patients, the role of IL-35 is controversial, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yago, Toru, Nanke, Yuki, Kawamoto, Manabu, Kobashigawa, Tsuyoshi, Yamanaka, Hisashi, Kotake, Shigeru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Society of Experimental and Clinical Immunology 2018
Materias:	Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102623/ https://www.ncbi.nlm.nih.gov/pubmed/30135626 http://dx.doi.org/10.5114/ceji.2018.77384

Ejemplares similares

RANK Expression and Osteoclastogenesis in Human Monocytes in Peripheral Blood from Rheumatoid Arthritis Patients
por: Nanke, Yuki, et al.
Publicado: (2016)

IL-23 and Th17 Disease in Inflammatory Arthritis
por: Yago, Toru, et al.
Publicado: (2017)

IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats
por: Yago, Toru, et al.
Publicado: (2007)

A novel peptide from TCTA protein inhibits proliferation of fibroblast-like synoviocytes of rheumatoid arthritis patients
por: Nanke, Yuki, et al.
Publicado: (2014)

Elevated Ratio of Th17 Cell-Derived Th1 Cells (CD161(+)Th1 Cells) to CD161(+)Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis Patients
por: Kotake, Shigeru, et al.
Publicado: (2016)

Ratio of Circulating IFNγ (+) “Th17 Cells” in Memory Th Cells Is Inversely Correlated with the Titer of Anti-CCP Antibodies in Early-Onset Rheumatoid Arthritis Patients Based on Flow Cytometry Methods of the Human Immunology Project
por: Kotake, Shigeru, et al.
Publicado: (2016)

Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts
por: Nanke, Yuki, et al.
Publicado: (2016)

The Role of T-Cell Leukemia Translocation-Associated Gene Protein in Human Tumorigenesis and Osteoclastogenesis
por: Kotake, Shigeru, et al.
Publicado: (2012)

The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis
por: Kotake, Shigeru, et al.
Publicado: (2017)

Effects of NSAIDs on Differentiation and Function of Human and Murine Osteoclasts – Crucial ‘Human Osteoclastology’
por: Kotake, Shigeru, et al.
Publicado: (2010)

A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet’s Disease with Crohn’s Disease-Like Anal Fistulas
por: Kobashigawa, Tsuyoshi, et al.
Publicado: (2014)

The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease
por: Nanke, Yuki, et al.
Publicado: (2017)

IL-35 and RANKL Synergistically Induce Osteoclastogenesis in RAW264 Mouse Monocytic Cells
por: Kamiya, Yosuke, et al.
Publicado: (2020)

NF-κB-Mediated Regulation of Osteoclastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2015)

The molecular mechanism of osteoclastogenesis in rheumatoid arthritis
por: Udagawa, Nobuyuki, et al.
Publicado: (2002)

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages
por: Jin, Gu, et al.
Publicado: (2018)

Isopsoralen suppresses receptor activator of nuclear factor kappa-β ligand-induced osteoclastogenesis by inhibiting the NF-κB signaling
por: Zhan, Wanda, et al.
Publicado: (2023)

Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway
por: Ren, Li-Rong, et al.
Publicado: (2017)

Cimifugin Suppresses NF-κB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis
por: Duan, Juan, et al.
Publicado: (2021)

TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
por: Yang, Wanlei, et al.
Publicado: (2021)

PARK2 Induces Osteoclastogenesis through Activation of the NF-κB Pathway
por: Hong, Seo Jin, et al.
Publicado: (2022)

The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
por: Novack, Deborah Veis, et al.
Publicado: (2003)

Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells
por: Shakibaei, Mehdi, et al.
Publicado: (2011)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
por: Quan, Gui-Hua, et al.
Publicado: (2015)

Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy
por: Wu, Dongle, et al.
Publicado: (2023)

TLR2 Ligands Induce NF-κB Activation from Endosomal Compartments of Human Monocytes
por: Brandt, Karim J., et al.
Publicado: (2013)

ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1β
por: Robaszkiewicz, Agnieszka, et al.
Publicado: (2016)

Staphylococcus aureus Protein A induces osteoclastogenesis via the NF-κB signaling pathway
por: Ren, Li-Rong, et al.
Publicado: (2017)

TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway
por: Luo, Gang, et al.
Publicado: (2018)

Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway
por: Hu, Xuanyang, et al.
Publicado: (2017)

Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF-κB signaling pathway
por: Chen, Yu, et al.
Publicado: (2021)

Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
por: Zhang, Fangxue, et al.
Publicado: (2021)

Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis
por: Lee, Won-Seok, et al.
Publicado: (2018)

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
por: Byrgazov, Konstantin, et al.
Publicado: (2021)

Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities
por: Joung, Youn Hee, et al.
Publicado: (2016)

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways
por: Wang, Wei, et al.
Publicado: (2020)

Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
por: Li, Xiucheng, et al.
Publicado: (2021)

Carnosol inhibits osteoclastogenesis in vivo and in vitro by blocking the RANKL-induced NF-κB signaling pathway
por: Cai, Pan, et al.
Publicado: (2022)

An Inducible, Ligand-Independent Receptor Activator of NF-κB Gene to Control Osteoclast Differentiation from Monocytic Precursors
por: Rementer, Cameron W., et al.
Publicado: (2013)

Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling
por: Ito, Fumitake, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vjlhcrrrb746oevrjpuumgc5kd